Why you shouldn't check your 401(k) during the coronavirus pandemic

Coronavirus aid bill includes $3,000 for families, $4 trillion liquidity for Fed: Mnuchin

The coronavirus economic relief bill being finalized by the U.S. Congress will include a one-time $3,000 payment for families and allow the Federal Reserve to leverage up to $4 trillion of liquidity to support the nation's economy, U.S. Treasury Secretary Steven Mnuchin said on Sunday. Mnuchin, speaking on the "Fox News Sunday" television program, said the additional liquidity measures would allow the U.S. central bank to help a broad base of businesses to get through next 90 to 120 days. Trump administration officials hoped to finalize the legislation on Sunday and see a vote on Monday, Mnuchin said, adding that further steps could be taken if the crisis did not abate in 10 to 12 weeks....

Danaher's Cepheid Receives FDA Emergency Use Authorization For 45-Minute Coronavirus Test

Late Friday night, the U.S. Food And Drug Administration approved the first coronavirus test that can be conducted entirely at the point of care for a patient and deliver results in 45 minutes.Cepheid's Xpert Xpress SARS-CoV-2 is a rapid molecular diagnostic test for qualitative detection of SARS-CoV-2, the virus causing COVID-19, the company said in a press release. The test has been designed to operate on any of Cepheid's more than 23,000 automated GeneXpert Systems worldwide.Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.At time of publication Sunday, the U.S. has a total of 26,747 confirmed COVID-19 cases, according Johns Hopkins University."During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities. An accurate test delivered close to the patient can...

3 Coronavirus Stocks with Over 60% Upside

In the battle against the coronavirus, who will be able to defeat this formidable foe? In the three months since the onset of this public health crisis, names from all over the world have stepped up, hoping their approach will ultimately yield success. Those at the front lines currently represent the U.S., Europe and China. As the outbreak escalated into a pandemic, even the most intense rivals have been working together to find solutions. However, at the end of the day, the fight underscores a geopolitical competition, with the first nation to produce an effective weapon against the virus potentially gaining an advantage both economically and in making sure their citizens are the first to receive it. Against this backdrop, we used TipRanks’ Stock Screener tool to find three healthcare names that are battling COVID-19. On top of receiving praise recently from at least one analyst, each boasts a healthy dose...